Ensysce Biosciences Inc (ENSC) — Strategic Asset Allocation Index
Ensysce Biosciences Inc (ENSC) has a Strategic Asset Allocation Index of 4.3% as of December 2025. Strategic assets (PP&E of $124.13K plus long-term investments of $-) total $124.13K, measured against net assets of $2.88 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Ensysce Biosciences Inc's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Ensysce Biosciences Inc Strategic Asset Allocation Index (2019–2019)
This chart shows how Ensysce Biosciences Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2019 to 2019. As of December 2025, the index stands at 4.3%, representing strategic assets of $124.13K against net assets of $2.88 Million USD. See ENSC FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Ensysce Biosciences Inc (2019–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Ensysce Biosciences Inc from 2019 to 2019, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ENSC stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 0.0% | $351.00 | $351.00 | $- | $186.17 Million | — |